首页> 美国卫生研究院文献>Oncology Letters >Long term results of hepatic resection or orthotopic liver transplantation in patients with liver metastases from gastrointestinal neuroendocrine tumors
【2h】

Long term results of hepatic resection or orthotopic liver transplantation in patients with liver metastases from gastrointestinal neuroendocrine tumors

机译:胃肠道神经内分泌肿瘤肝转移患者肝切除或原位肝移植的长期结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hepatic metastases are one of the most important prognostic factors for survival among patients affected by gastrointestinal neuroendocrine tumors (NETs). The present study aims to evaluate the impact of surgery, including hepatic resection or orthotopic liver transplantation (OLT), on the outcome of patients affected by hepatic metastases from NETs, in terms of overall survival (OS). In this multicentric retrospective study, data was collected on 26 patients, who underwent surgery for hepatic metastases from NETs in two Italian University Clinics between January 1990 and December 2012; of which, 22 patients underwent hepatic resective surgery and 4 patients OLT. Hepatic metastases were synchronous in the 53.8% of cases and metachronous in the 46.2% of cases. The median number of resected hepatic metastases was 3. Surgical radicalness (R0) was reached in the 84.6% of cases. In total, 57.7% of patients had a recurrence, 66.7% of which were intra- and 33.3% extra-hepatic. The OS of patients that underwent hepatic resections and OLT was 44.9% [95% confidence interval (CI95), 26.0–77.7%] and 50% (CI95, 12.5–100.0%) at 5 years, respectively. Although the data regarding the survival of patients receiving surgery for hepatic metastases from NETs are encouraging, randomized clinical trials are necessary to more adequately evaluate the effect of surgery on survival of this group of patients.
机译:肝转移是胃肠道神经内分泌肿瘤(NETs)影响的患者生存最重要的预后因素之一。本研究旨在从整体生存率(OS)方面评估手术(包括肝切除术或原位肝移植(OLT))对受NETs肝转移影响的患者预后的影响。在这项多中心回顾性研究中,收集了1990年1月至2012年12月在意大利两家大学诊所的NETs进行肝转移手术的26例患者的数据。其中22例接受了肝切除手术,4例接受了OLT。肝转移在53.8%的病例中是同步的,在46.2%的病例中是异时的。切除的肝转移的中位数为3。在84.6%的病例中达到了手术根治性(R0)。总共有57.7%的患者复发,其中66.7%是肝内复发和33.3%是肝外复发。接受肝切除和OLT的患者在5年时的OS分别为44.9%[95%置信区间(CI95),26.0-77.7%]和50%(CI95,12.5-100.0%)。尽管有关接受NETs进行肝转移手术的患者生存率的数据令人鼓舞,但仍需要进行随机临床试验以更充分地评估手术对这一组患者生存的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号